All Content

This podcast discusses preliminary evidence about the effects of karate on quality of life and several measures of gait, balance, and mobility in patients with PD.

What’s in your differential diagnosis for this cachectic, disheveled patient who can no longer carry on a coherent conversation?

Does the clinical picture point to a reaction to alcohol? A food allergy? What do you suspect is the likely culprit?

Emgality (galcanezumab-gnlm) is the first FDA-approved drug that reduces the frequency of headache attacks.

Are his symptoms related to a fall that occurred 2 years earlier at work?

Current recommendations suggest screening for autism starting at 18 months, but parents are increasingly anxious about their children and a possible diagnosis.

College athletes may be sabotaging their careers—as well as their performance—when they sacrifice sleep for sports, studying, and socializing.

A new tool to add to your armamentarium?

What’s new in MS: teratogenicity of disease-modifying drugs, extended interval natalizumab dosing, a potential biomarker, the “MS hug,” and virtual reality therapy.

Around three times more women than men have migraine. This marked difference in prevalence is one of the most well-known features of the illness. Here's what history tells us.

A combination of biomarkers that might assist physicians in differentiating syncope from seizure; LiTT for intractable mesial temporal lobe epilepsy—these and other insights.

Autism diagnostic stability starts early, much MS misdiagnosis and unnecessary medication, CBD reduces seizures in children, and other recent findings are summarized here.